Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / BIOV:CC - BioVaxys acquires TAETSoftware to utilize Trial Adverse Events Tracker platform

BIOV:CC - BioVaxys acquires TAETSoftware to utilize Trial Adverse Events Tracker platform

Biovaxys Technology Corp.

--News Direct--

BioVaxys CEO James Passin joins Natalie Stoberman from the Proactive newsroom to discuss the company's acquisition of TAETSoftware, a Vancouver-based clinical studies management company engaged in the development and commercialization of the Trial Adverse Events Tracker (TAET) technology platform.

Passin says the acquisition of TAETCO provides BioVaxys with a third low-risk near-term revenue generating product, supporting its core business in cancer and viral vaccine development.

Contact Details

Proactive Canada

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/biovaxys-acquires-taetsoftware-to-utilize-trial-adverse-events-tracker-platform-561619622

Stock Information
Company Name: Biovaxys Technology Corp.
Stock Symbol: BIOV:CC
Market: CNQC
Website: biovaxys.com
Menu
BIOV:CC BIOV:CC Quote BIOV:CC Short BIOV:CC News BIOV:CC Articles BIOV:CC Message Board
Get BIOV:CC Alerts

News, Short Squeeze, Breakout and More Instantly...